Sodium-glucose cotransporter 2 inhibition, epidermal growth factor, and magnesium homeostasis: is there a link? Reply

被引：0
|
作者：
Ju, Wenjun [1 ,2 ]
Heerspink, Hiddo J. L. [3 ,4 ,7 ]
Kretzler, Matthias [1 ,2 ]
Bjornstad, Petter [5 ,6 ]
Bjornstad, Petter [5 ,6 ]
机构：
[1] Univ Michigan, Dept Internal Med, Div Nephrol, Ann Arbor, MI USA
[2] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI USA
[3] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
[4] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia
[5] Univ Colorado, Dept Pediat, Sect Endocrinol, Sch Med, Aurora, CO USA
[6] Univ Colorado, Dept Med, Div Renal Dis & Hypertens, Sch Med, Aurora, CO USA
[7] Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, De Brug 50C-1-011,AP50,POB 30001, NL-9700 AD Groningen, Netherlands
来源：
KIDNEY INTERNATIONAL | 2024年 / 105卷 / 03期
关键词：
D O I：
10.1016/j.kint.2023.10.033
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：639 / 639
页数：1
相关论文
共 50 条
  • [31] Heart and Sodium-Glucose Cotransporter 2 Inhibitors: A Sodium Dilemma
    Oyesomi, Elizabeth T.
    Tabrizchi, Reza
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2022, 79 (05) : 641 - 643
  • [32] Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Nephrolithiasis in Clinical Practice-Reply
    Paik, Julie M.
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2024, 184 (07)
  • [33] Sodium-Glucose Cotransporter 2 Inhibitors and Cardiac Remodeling
    Husam M. Salah
    Subodh Verma
    Carlos G. Santos-Gallego
    Ankeet S. Bhatt
    Muthiah Vaduganathan
    Muhammad Shahzeb Khan
    Renato D. Lopes
    Subhi J. Al’Aref
    Darren K. McGuire
    Marat Fudim
    Journal of Cardiovascular Translational Research, 2022, 15 : 944 - 956
  • [34] Sodium-glucose cotransporter 2 inhibitors and emphysematous cystitis
    Dubin, Ina
    Glick, Yair
    Schattner, Ami
    POSTGRADUATE MEDICAL JOURNAL, 2024, 100 (1190) : 946 - 947
  • [35] CARDIOPROTECTIVE MECHANISMS OF SODIUM-GLUCOSE COTRANSPORTER 2 INHIBITORS
    Mkrtumyan, Ashot M.
    Markova, Tatyana N.
    Mishchenko, Nadezhda K.
    DIABETES MELLITUS, 2021, 24 (03): : 291 - 299
  • [36] Investigating the place of sodium-glucose cotransporter-2 inhibitors and dual sodium-glucose cotransporter-1 and dual sodium-glucose cotransporter-2 inhibitors in heart failure therapy: a systematic review of the literature
    Mckenzie, Taylor
    Hale, Genevieve M.
    Miner, Amelia
    Colon, Jean Colon
    Evins, Garrett
    Wade, Jasmine
    HEART FAILURE REVIEWS, 2024, 29 (02) : 549 - 558
  • [37] Evaluation of the Association of Single Nucleotide Polymorphisms in the Sodium-Glucose Cotransporter 2 Gene with Glucose Homeostasis and Type 2 Diabetes
    Muendlein, Axel
    Ebner, Janine
    Leiherer, Andreas
    Saely, Christoph H.
    Geiger, Kathrin
    Brandtner, Eva M.
    Zanolin, Daniela
    Vonbank, Alexander
    Fraunberger, Peter
    Drexel, Heinz
    DIABETES, 2017, 66 : A508 - A508
  • [38] Benefits and Complications of Sodium-Glucose Cotransporter 2 Inhibitors
    Sangiovanni, Ryan J.
    DeVee, Carley E.
    US PHARMACIST, 2019, 44 (02) : HS9 - HS12
  • [39] Lipid effects of sodium-glucose cotransporter 2 inhibitors
    Lazarte, Julieta
    Kanagalingam, Tharsan
    Hegele, Robert A.
    CURRENT OPINION IN LIPIDOLOGY, 2021, 32 (03) : 183 - 190
  • [40] Sodium-Glucose Cotransporter 2 Inhibitors in Heart Failure
    Shah, Kevin S.
    Fang, James C.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2022, 62 : 109 - 120
12345